Recent Publications

Peer Reviewed Articles

Abubakar SB, Abubakar IS, Habib AG, Nasidi A, Durfa N, Yusuf PO, Larnyang S, Garnvwa J, Sokomba E, Salako L, Theakston RD, Juszczak E, Alder N, Warrell DA; for the Nigeria-UK EchiTab Study Group. Randomised controlled double-blind non-inferiority trial of two antivenoms for saw-scaled or carpet viper (Echis ocellatus) envenoming in Negeria. PLoS Negl Trop Dis 2010; 4: e767.

Abubakar SB, Abubakar IS, Habib AG, Nasidi A, Durfa N, Yusuf PO, Larnyang S, Garnvwa J, Sokomba E, Salako L, Laing GD, Theakston RD, Juszczak E, Alder N, Warrell DA; for the Nigeria-UK EchiTab Study Group. Pre-clinical and preliminary dose-finding and safety studies to identify candidate antivenoms for treatment of envenoming by saw-scaled or carpet vipers (Echis ocellatus) in northern Nigeria. Toxicon 2010; 55: 719-723.

Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Int J Nurs Stud 2010; 47: 931-936.

Boutron I, Dutton S, Ravaud P, Altman DG. Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes. JAMA 2010; 303: 2058-2064.

Chambers W, Collins G, Warren B, Cunningham C, Mortensen N, Lindsey I. Benchmarking circumferential resection margin (R1) resection rate for rectal cancer in the neoadjuvant era. Colorectal Dis 2010; 12: 909-913.

Collins GS, Altman DG. An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study. BMJ 2010; 340: c2442.

Dechartres A, Charles P, Hopewell S, Ravaud P, Altman DG. Reviews assessing the quality of reporting of randomized controlled trials are increasing over time but raised questions about how quality is assessed. J Clin Epidemiol 2010 Aug 11 [Epub ahead of print].

de Jager CA, Honey TE, Birks J, Wilcock GK. Retrospective evaluation of revised criteria for the diagnosis of Alzheimer's disease using a cohort with post-mortem diagnosis. Int J Geriatr Psychiatry 2010 Mar 9 [Epub ahead of print]

Geddes JR, Goodwin GM, Rendell J, Azorin JM, Cipriani A, Ostacher MJ, Morriss R, Alder N, Juszczak E. Lithum plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. Lancet 2010; 375: 385-395.

Glasziou P, Chalmers, I, Altman DG, Bastian H, Boutron I, Brice A, Jamtvedt G, Farmer A, Ghersi D, Groves T, Heneghan C, Hill S, Lewin S, Michie S, Perera R, Pomeroy V, Tilson J, Shepperd S, Willams JW. Taking healthcare interventions from trial to practice. BMJ 2010; 341: c3852.

Hopewell S, Dutton S, Yu LM, Chan AW, Altman DG. The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed. BMJ 2010; 340: c723.

Hrynaszkiewicz I,Norton ML, Vickers AJ, Altman DG. Preparing raw clinical data for publication: guidance for journal editors, authors and peer reviewers. BMJ 2010; 340:c181.

Hrynaszkiewicz I,Norton ML, Vickers AJ, Altman DG. Preparing raw clinical data for publication: guidance for journal editors, authors and peer reviewers. Trials 2010; 11:9.

Kent DM, Rothwell PM, Ioannidis JP, Hayward RA, Altman DG. Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal. Trials 2010; 11: 85.

Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Reporting in vivo experiments: The ARRIVE guidelines. Br J Pharmacol 2010; 160: 1577-1579.

Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research. PLoS Biol 2010; 8: e1000412.

Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Animal Research: Reporting in vivo experiments: the ARRIVE guidelines. J Gene Med 2010; 12: 561-563.

Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Animal Research: Reporting in vivo experiments: the ARRIVE guidelines. Exp Physiol 2010; 95: 842-844.

Kilkenny C, Altman DG. Improving bioscience research reporting: ARRIVE-ing at a solution. Lab Anim 2010 Jul 21 [Epub ahead of print].

Kirkham JJ, Altman DG, Williamson PR. Bias due to changes in specified outcomes during the systematic review process. PLoS One 2010; 5: e9810.

Kirkham JJ, Dwan DW, Altman DG, Gamble C, Dodd S, Smyth R, Williamson PR. The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews. BMJ 2010; 340: c365.

MacPherson H, Altman DG, Hammerschlag R, Youping L, Taixiang W, White A, Moher D. Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement. Acupunct Med 2010; 28: 83-93.

MacPherson H, Altman DG, Hammerschlag R, Youping L, Taixiang W, White A, Moher D. Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement. PLoS Med 2010; 7: e1000261.

Mallett S, Royston P, Dutton S, Waters R, Altman DG. Reporting methods in studies developing prognostic models in cancer: a review. BMC Med 2010; 8:20.

Mallett S, Royston P, Waters R, Dutton S, Altman DG. Reporting performance of prognostic models in cancer: a review. BMC Med 2010; 8:21.

Mallett S, Timmer A, Sauerbrei W, Altman DG. Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines. Br J Cancer 2010; 102: 173-180.

Marshall A, Altman DG, Royston P, Holder RL. Comparison of techniques for handling missing covariate data within prognostic modelling studies - a simulation study. BMC Med Res Meth 2010; 10:7.

Moher D, Hopewell S, Schulz K, Montori V, Gøtzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG. CONSORT 2010 Explanation and elaboration: Updated guidelines for reporting parallel group randomised trials. BMJ 2010; 340: c689.

Moher D, Hopewell S, Schulz K, Montori V, Gøtzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG. CONSORT 2010 Explanation and elaboration: Updated guidelines for reporting parallel group randomized trials. J Clin Epidemiol 2010; 63: 834-840.

Moher D, Hopewell S, Schulz K, Montori V, Gøtzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG. CONSORT 2010 Explanation and elaboration: Updated guidelines for reporting parallel group randomized trials. Zhong Xi Yi Jie He Xue Bao. 2010; 8: 701-741. [in Chinese]

Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Int J Surg 2010; 8:336-341.

Moher D, Schulz KF, Simera I, Altman DG. Guidance for developers of health research reporting guidelines. PLoS Med 2010; 7: e1000217.

Norwood MG, Bailey N, Nanji M, Gillies RS, Nicholson A, Ubhi S, Darnton JJ, Steyn RS, Womack C, Hughes A, Hemingway D, Harrison R, Waters R, Jankowski JA. Cytoplasmic beta-catenin accumulation is a good prognostic marker in upper and lower gastrointestinal adenocarcinomas. Histopathology 2010; 57: 101-111.

Nuesch E, Trelle S, Reichenbach S, Rutjes AW,  Tschannen B, Altman DG, Egger M, Juni P.  Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study. BMJ 2010; 341: c3515.

Perrett KP, Winter AP, Kibwana E, Jin C, John TM, Yu LM, Borrow R, Curtis N, Pollard DJ.  Antibody persistence after serogroup C meningococcal conjugate immunization of United Kingdom primary-school children in 1999-2000 and response to a booster: a phase 4 clinical trial. Clin Infect Dis 2010; 50: 1601-1610.

Reyes-Sandoval A,Berthoud T, Alder N, Siani L, Gilbert SC, Nicosia A, Colloca S, Cortese R, Hill AV. Prime-boost immunization with adenoviral and modified vaccinia virus ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+T-cell responses. Infect Immun 2010; 78: 145-153.

Royston P, Altman DG. Visualizing and assessing discrimination in the logistic regression model. Stat Med 2010 Jul 19 [Epub ahead of print].

Schriger DL, Altman DG, Vetter JA, Heafner T, Moher D. Forest plots in reports of systematic reviews: a cross-sectional study reviewing current practice. Int J Epidemiol 2010; 39: 421-429.

Schulz K, Altman DG, Moher D for the CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010; 340: c332.

Schulz K, Altman DG, Moher D for the CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med 2010; 8: 18.

Schulz K, Altman DG, Moher D for the CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med 2010; 52: 726-732.

Schulz K, Altman DG, Moher D for the CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. Trials 2010; 11: 32.

Schulz K, Altman DG, Moher D for the CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. PLoS Med 2010; 7: e1000251.

Schulz K, Altman DG, Moher D for the CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomized trials. Open Med 2010; 4: e60.

Schulz K, Altman DG, Moher D for the CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol 2010; 63: 834-840.

Schulz K, Altman DG, Moher D for the CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomized trials. Obstet Gynecol 2010; 115: 1063-1070.

Schulz K, Altman DG, Moher D for the CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomized trials (Chinese version). Zhong Xi Yi Jie He Xua Bao 2010; 8: 604-612.

Schulz K, Altman DG, Moher D for the CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. Lancet 2010. Web appendix to Schulz KF, Altman DG, Moher D, Fergusson D. CONSORT 2010 changes and testing blindness in randomised trials. Lancet 2010; 375: 1144-1146.

Schulz K, Altman DG, Moher D, Fergusson D. CONSORT 2010 changes and testing blindness in RCTs. Lancet 2010; 375: 1144-1146.

Sills ES, Collins GS, Walsh DJ, Omar AB, Salma U, Walsh APH. A descriptive study of selected oocyte, blood and organ/tissue donation features among fertility patients in Ireland. Human Fertility 2010; 13: 98-104.

Simera I, Moher D, Hoey J, Schulz KF, Altman DG. A catalogue of reporting guidelines for health research. Eur J Clin Invest 2010; 40: 35-53.

Taggart DP, Altman DG, Gray AM, Lees B, Nugara F, Yu LM, Campbell H, Flather M; on behalf of the ART Investigators. Randomized trial to compare bilateral vs single internal mammary coronary artery bypass grafting: 1-year results of the Arterial Revascularization Trial (ART). Eur Heart J 2010 Aug 30 [Epub ahead of print].

Taylor C, Sippitt JM, Collins G, McManus C, Richardson A, Dawson J, Richards M, Ramirez AJ.  A pre-post test evaluation of the impact of the PELICAN MDT-TME Development Programme on the working lives of colorectal cancer team members. BMC Health Serv Res 2010; 10: 187.

Vergouwe Y, Royston P, Moons KGM, Altman DG. Development and validation of a prediction model with missing prediction data: a practical approach. J Clin Epidemiol 2010; 63: 205-214.

Walsh APH, Omar AB, Collins GS, Murrary GU, Walsh DJ, Salma U, Sills ES. Application of EU Tissue and Cell Directive screening protocols to anonymous oocyte donors in western Ukraine: Data from an Irish IVF programme. J Obstet Gynaecol 2010; 30: 613-616.

Yu LM, Chan AW, Hopewell S, Deeks J, Altman DG. Reporting on covariate adjustment in randomised controlled trials before and after revision of the 2001 CONSORT statement: a literature review. Trials 2010; 11:59.